Static Image
Announcing the New Breaking the Arthritis Pain Chain Toolkit

Announcing the New Breaking the Arthritis Pain Chain Toolkit

When you think of arthritis one of the first things that comes to mind is pain. Pain can be all consuming; whether it’s burning, aching, or stiffness it’s not only an annoyance, it can affect every aspect of your life. You shouldn’t have to just “live” with the pain either. It is possible to manage your pain and improve your quality of life. The Arthritis Foundation has developed a new toolkit – Breaking the Arthritis Pain Chain – so you can break this vicious pain cycle. The toolkit includes four important sections of information that break down what causes your pain ...more
September 28th Marks the First Annual Psoriatic Arthritis Awareness Day

September 28th Marks the First Annual Psoriatic Arthritis Awareness Day

Wednesday, September 28, 2016 is the first-ever nationwide Psoriatic Arthritis (PsA) Awareness Day, enacted to raise awareness of the painful inflammatory disease that may develop in conjunction with psoriasis. Approximately 30% of people with psoriasis, the skin disease that causes dryness, itchiness or scaly rashes, also develop psoriatic arthritis, which can affect the entire body and may lead to permanent joint and tissue damage if not identified and treated early and aggressively. Currently, more than one million Americans live with PsA, although this number may be higher, as the disease may be underreported. Who is at Risk for PsA? PsA usually appears between the ages ...more
FDA Approves Third Biosimilar for Arthritis - Amjevita, a Biosimilar to Humira

FDA Approves Third Biosimilar for Arthritis - Amjevita, a Biosimilar to Humira

The U.S. Food and Drug Administration (FDA) on Friday approved the third biosimilar to treat inflammatory types of arthritis – but, like the two that were previously approved, this one will not be available to patients until patent disputes are resolved. Adalimumab-atto (brand name Amjevita) is a biosimilar to the blockbuster drug adalimumab (Humira). It was approved to treat adults with rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA), psoriasis, Crohn’s disease and ulcerative colitis. It was also approved to treat children age 4 and older with polyarticular juvenile idiopathic arthritis (pJIA). The approval of adalimumab-atto follows the August approval of ...more
Living Your Yes With RA – Join us for a Personalized Goal Setting Event

Living Your Yes With RA – Join us for a Personalized Goal Setting Event

If you have Rheumatoid Arthritis, you understand the difficulties it brings – joint pain, swelling, stiffness, fatigue. It can be hard to not let it affect your life. We want to help you change that so you can start saying Yes more than No. You shouldn’t have to struggle, that’s why we created Living Your Yes With RA – a personalized goal-setting event for people with RA. These events will equip you with tools so you can start expecting more from your treatment, like low-disease activity and remission. It’s possible, and we will help. Living Your Yes With RA will take ...more
8 Days, 525 Miles – Biking the California Coast For a Cure!

8 Days, 525 Miles – Biking the California Coast For a Cure!

On Saturday, September 24, 2016, the Arthritis Foundation’s 16th Annual California Coast Classic Bike Tour will take off from Pier 39 on the beautiful bay of San Francisco. Over 250 riders will embark on an 8-day tour down the coast of California’s famous Highway 1, stopping along the way in Santa Cruz, Monterey, Big Sur, Cambria, Oceano, Buellton, Ventura and concluding on October 1 in Pacific Palisades of Los Angeles. Celebrating its 16th consecutive year, the “CCC” brings together riders of all ages from all over the world – with some coming from as far as England and New York, to ...more
New Hampshire Volunteer Focused on a Cure

New Hampshire Volunteer Focused on a Cure

Tom Raffio is a true Champion of Yes. Though not personally affected by arthritis, Tom, a dedicated volunteer, has made it his mission to help educate, fundraise and advocate for the millions of Americans living with the disease. “Until everyone is comfortable talking about arthritis, until there is a sea of green during the walks, I will not settle,” Tom said. For the past three years, Tom has acted as chairman of his local New Hampshire leadership board and is helping make sure others know the profound impact of arthritis. As president and CEO of Northeast Delta Dental, he’s able to use his ...more
From Gymnastics Gold to JA: How Gymnastics & Juvenile Arthritis Changed Marina Gomez’s Life

From Gymnastics Gold to JA: How Gymnastics & Juvenile Arthritis Changed Marina Gomez’s Life

Marina Gomez of Wichita, KS has been a gymnast since she was just 4-years-old. In 2012 and 2013 she won consecutive gold medals at the Junior Olympic National Championship in competitive trampoline. Marina was looking forward to a long gymnastics career but after she was diagnosed with juvenile arthritis (JA) in 2013, her gymnastics career was cut short. Marina Gomez Marina’s first time competing at the Junior Olympic National Championship in 2012, she won gold in her event. Marina was training at least 18 hours a week and pushing her body to the limits. Shortly after returning home from her first ...more
Biologics Appear Safe for Some Rheumatoid Arthritis Patients Who’ve Had Cancer

Biologics Appear Safe for Some Rheumatoid Arthritis Patients Who’ve Had Cancer

Researchers set out to answer a pressing question: Is it safe for rheumatoid arthritis (RA) patients who have had cancer in the past to use a biologic drug rather than a traditional disease-modifying antirheumatic drug (DMARD), like methotrexate, to control their disease? Their answer, detailed in a study recently published online in the journal Rheumatology, is reassuring. They found that patients with a previous malignancy who later took certain biologics did not appear to have an increased risk of cancer after an average of five years, compared to those who took a traditional DMARD. The immune system is at the root ...more
Spotlight on Debra Lappin - Patient, Advocate & Volunteer

Spotlight on Debra Lappin - Patient, Advocate & Volunteer

The Arthritis Foundation is truly fortunate to have a network of dedicated volunteers, engaged constituents and committed board leaders helping us move our mission forward. Today’s spotlight focuses on someone very special to the foundation that is all three of those things. Debra R. Lappin, JD is a former national chair of the Arthritis Foundation and is currently a patient advocate volunteering on our behalf with the National Institutes of Health’s (NIH) Accelerating Medicines Partnership. How Debra came to be involved with the Arthritis Foundation is quite the story – In her late 20s, Ms. Lappin was embarking on a promising ...more
2015 Annual Report Published: Great Strides Paving the Way to Yes

2015 Annual Report Published: Great Strides Paving the Way to Yes

The Arthritis Foundation is proud of the new directions we’ve taken over the past couple of years. We’ve shifted our attention to make the biggest and best impact on people’s lives. We’ve gotten more focused, strategic, streamlined and personalized. 2015 may seem like long ago now, but it was a landmark year. And it is now part of our rich history over seven decades of remarkable experience. For a snapshot of pivotal milestones that led to today’s work, check out the Arthritis Foundation’s 2015 annual report. As our infographics show: We rallied behind 159 bills in 46 states, leading to 44 new laws that ...more